查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1866350

全球眼科器材市場－2025-2030年預測

Global Ophthalmic Devices Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 148 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計眼科設備市場將從 2025 年的 212.38 億美元成長到 2030 年的 292.35 億美元，複合年成長率為 6.60%。

由於視力障礙病例增加、人口老化以及生活方式的改變，眼科疾病的盛行率不斷上升，全球眼科器械市場預計將迎來顯著成長。眼科器械對於矯正白內障、青光眼、視網膜疾病、糖尿病眼科疾病等引起的視力問題至關重要，同時也有助於近視和遠視患者實現無鏡片視力。隨著可支配收入的增加、技術創新以及在預防可預防性失明方面投入的不斷成長，人們對先進治療方法的需求日益增加，預計該市場將繼續擴張。

市場促進因素

視力障礙和可預防性失明的增加

視力障礙的日益增多是眼科成長要素。各國政府和衛生組織越來越關注可預防性失明，並因此增加對視力保健的投入。白內障是導致可預防性失明的主要原因，每年影響1億隻眼睛，尤其是在老年人族群。青光眼每年影響超過6000萬人，逐漸損害視神經。同時，乾眼症每年影響超過3.34億患者，導致視力障礙。視網膜疾病，包括糖尿病黃斑部水腫（DME）和視網膜靜脈阻塞（RVO），每年導致2000萬至2500萬人嚴重失明。糖尿病、心血管疾病和肥胖等慢性疾病加劇了這一風險，佔全球每年死亡人數的51%。預計到2050年，約有48億人（佔世界人口的一半）將患有近視，這將進一步推動對眼科設備的需求。諾華等公司正在開發用於治療青光眼的神經保護療法，這表明該行業致力於透過創新解決方案來應對這些挑戰。

生活方式和職場環境的變化

現代生活方式的趨勢，尤其是智慧型手機、平板電腦和智慧電視等電子設備的日益普及，正在加劇各個年齡層的視力問題。長時間的螢幕使用，加上遠距辦公和線上教育的盛行，給視神經造成了巨大的壓力，並導致近視和遠視的增加。這種職場文化的轉變，加上遠距辦公的持續發展，使得學生和職場人士的螢幕使用時間不斷增加，視力矯正設備的需求也隨之擴大。數位設備的日益普及凸顯了開發先進的眼科解決方案以緩解相關眼部疲勞和視力問題的必要性。

市場展望

受人口老化和慢性疾病（這些疾病會加劇眼科疾病）的推動，眼科器材市場預計到2030年將保持強勁成長。視力矯正和治療設備的科技進步，以及醫療保健投資的不斷成長，進一步提振了市場前景。可支配收入的快速成長支撐了對高品質治療的需求，而與生活方式相關的視力問題也確保了各類人群對眼科解決方案的需求。產業相關人員必須優先考慮創新和可及性，才能抓住這些成長機會，同時應對全球視力保健挑戰，尤其是在中低收入國家，因為89%的視覺障礙者居住在這些國家。

本報告的主要優勢：

  • 深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
  • 競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略打入市場的潛力。
  • 市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
  • 可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
  • 受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

  • 歷史資料（2022-2024 年）和預測資料（2025-2030 年）
  • 成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
  • 競爭對手定位、策略和市場佔有率分析
  • 按業務板塊和地區（國家）分類的收入成長和預測分析
  • 公司概況（策略、產品、財務資訊、關鍵趨勢等）

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 分析範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策和法規
  • 策略建議

第4章 技術展望

第5章 全球眼科器材市場（按類型分類）

  • 介紹
  • 手術器械
    • 持針器
    • 鉗子
    • 牽開器/眼底鏡
    • 其他
  • 診斷設備
    • 眼底鏡
    • 眼壓計
    • 分析器
    • 其他
  • 視力保健產品
    • 隱形眼鏡
    • 眼鏡
  • 其他

6. 全球眼科設備市場（按應用分類）

  • 介紹
  • 白內障
  • 青光眼
  • 屈光不正
    • 近視
    • 遠見
  • 其他

7. 全球眼科設備市場（依最終用戶分類）

  • 介紹
  • 醫院和診所
  • 門診手術中心
  • 其他

8. 全球眼科器材市場（按地區分類）

  • 介紹
  • 北美洲
    • 按類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 美國
      • 加拿大
      • 墨西哥
  • 南美洲
    • 按類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 巴西
      • 阿根廷
      • 其他
  • 歐洲
    • 按類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 德國
      • 法國
      • 英國
      • 義大利
      • 西班牙
      • 其他
  • 中東和非洲
    • 按類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 以色列
      • 其他
  • 亞太地區
    • 按類型
    • 透過使用
    • 最終用戶
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 印尼
      • 泰國
      • 台灣
      • 其他

第9章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 企業合併、協議、商業合作
  • 競爭對手儀錶板

第10章：公司簡介

  • Johnson & Johnson
  • Bausch & Lomb Incorporated
  • Carl Zeiss AG
  • Essilor
  • Nidek Co Ltd
  • Topcon Corporation
  • Ziemer Ophthalmic Systems
  • Alcon Vision LLC
  • Hoya Corporation
  • Haag-Streit Group

第11章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 分析方法
  • 簡稱
簡介目錄
Product Code: KSI061611179

The Ophthalmic Devices Market will grow from USD 21.238 billion in 2025 to USD 29.235 billion by 2030, fueled by a 6.60% compound annual growth rate (CAGR).

The global ophthalmic devices market is poised for significant growth, driven by rising vision impairment cases, an aging population, and lifestyle changes increasing the prevalence of eye disorders. Ophthalmic devices, essential for correcting vision issues caused by conditions like cataracts, glaucoma, retinal disorders, and diabetic eye problems, also facilitate lens-free vision for myopia and hyperopia. The market is expected to expand due to heightened demand for advanced treatments, fueled by growing disposable incomes, technological innovations, and increased investments in combating preventable blindness.

Market Drivers

Rising Vision Impairment and Preventable Blindness

The escalating prevalence of vision impairment is a primary growth driver. Governments and health organizations are increasingly concerned about preventable blindness, prompting significant investments in vision care. Cataracts, a leading cause of preventable blindness, affect 100 million eyes annually, particularly among the aging population. Glaucoma, impacting over 60 million people yearly, progressively damages the optic nerve, while dry eye disease affects more than 334 million patients annually, impairing vision. Retinal diseases, including Diabetic Macular Edema (DME) and Retinal Vein Occlusion (RVO), cause severe vision loss in 20-25 million people each year, with risks amplified by chronic conditions like diabetes, cardiovascular diseases, and obesity, which account for 51% of global deaths annually. By 2050, approximately 4.8 billion people-half the global population-are projected to have myopic vision, further driving demand for ophthalmic devices. Companies like Novartis are advancing neuroprotective therapies for glaucoma, underscoring the industry's focus on innovative solutions to address these challenges.

Lifestyle Changes and Work Culture

Modern lifestyle trends, particularly the increased use of electronic devices such as smartphones, tablets, and smart TVs, are intensifying vision-related issues across all age groups. Prolonged screen time, exacerbated by remote work and digital education, significantly strains optic nerves, contributing to a rise in myopia and hyperopia. This shift in work culture, with sustained remote operations, has expanded the patient base for vision correction devices, as screen time continues to increase among both students and professionals. The growing penetration of digital devices underscores the need for advanced ophthalmic solutions to mitigate associated eye strain and vision impairment.

Market Outlook

The ophthalmic devices market is set to grow robustly through 2030, propelled by the rising geriatric population and chronic disease prevalence, which exacerbate eye conditions. Technological advancements in vision correction and treatment devices, coupled with increased healthcare investments, will enhance market prospects. The surge in disposable incomes supports demand for high-quality treatments, while lifestyle-driven vision issues ensure a broad demographic need for ophthalmic solutions. Industry stakeholders must prioritize innovation and accessibility, particularly in low- and middle-income countries where 89% of vision-impaired individuals reside, to capitalize on these growth opportunities while addressing global vision care challenges.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Type

  • Surgical Device
  • Needle Holders
  • Forceps
  • Retractors & Speculum
  • Others
  • Diagnostics Device
  • Ophthalmoscope
  • Tonometer
  • Phoropter
  • Others
  • Vision Care Products
  • Contact Lenses
  • Spectacles
  • Others

By Application

  • Cataract
  • Glaucoma
  • Refractive Errors
  • Myopia
  • Hyperopia
  • Others

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL OPHTHALMIC DEVICES MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Surgical Device
    • 5.2.1. Needle Holders
    • 5.2.2. Forceps
    • 5.2.3. Retractors & Speculum
    • 5.2.4. Others
  • 5.3. Diagnostics Device
    • 5.3.1. Ophthalmoscope
    • 5.3.2. Tonometer
    • 5.3.3. Phoropter
    • 5.3.4. Others
  • 5.4. Vision Care Products
    • 5.4.1. Contact Lenses
    • 5.4.2. Spectacles
  • 5.5. Others

6. GLOBAL OPHTHALMIC DEVICES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cataract
  • 6.3. Glaucoma
  • 6.4. Refractive Errors
    • 6.4.1. Myopia
    • 6.4.2. Hyperopia
  • 6.5. Others

7. GLOBAL OPHTHALMIC DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hopsitals & Clinics
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. GLOBAL OPHTHALMIC DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Italy
      • 8.4.4.5. Spain
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Israel
      • 8.5.4.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. India
      • 8.6.4.3. Japan
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Johnson & Johnson
  • 10.2. Bausch & Lomb Incorporated
  • 10.3. Carl Zeiss AG
  • 10.4. Essilor
  • 10.5. Nidek Co Ltd
  • 10.6. Topcon Corporation
  • 10.7. Ziemer Ophthalmic Systems
  • 10.8. Alcon Vision LLC
  • 10.9. Hoya Corporation
  • 10.10. Haag-Streit Group

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations